🇺🇸 FDA
Pipeline program

Shexiang Baoxin pill

SBP-2016

Approved small_molecule active

Quick answer

Shexiang Baoxin pill for Coronary Artery Disease(CAD) is a Approved program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Coronary Artery Disease(CAD)
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials